Allison G. Chunyk

Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma

Siler H. Panowski, Tracy C. Kuo, Yi Zhang et al. · Molecular Cancer Therapeutics · 2019 · 45 citations

An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity

Yik A. Yeung, Veena Krishnamoorthy, Danielle Dettling et al. · Molecular Therapy · 2020 · 41 citations · Full text

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

Maria José Costa, Jyothirmayee Kudaravalli, Jing-Tyan Ma et al. · Scientific Reports · 2019 · 21 citations · Full text

Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform

Tracey Clark, Phillip D. Yates, Allison G. Chunyk et al. · The AAPS Journal · 2016 · 18 citations

Gyrolab Platform, Engineering, Biochemistry +15

A Multi-site In-depth Evaluation of the Quanterix Simoa from a User’s Perspective

Allison G. Chunyk, Alison Joyce, Saloumeh K Fischer et al. · The AAPS Journal · 2017 · 18 citations

Multi-site In-depth Evaluation, Engineering, Quanterix Simoa +5